Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: GI Dynamics, Inc.

Market Cap 440K 381K 351K 329K 616K 41.89M 625K 4.16M 1.61M 20.38M 1.65M 1.62M 70.56M P/E Ratio 2019
-1.12x
P/E Ratio 2020 -0.03x
Enterprise Value 3.28M 2.84M 2.61M 2.45M 4.59M 312M 4.66M 30.95M 12.02M 152M 12.31M 12.04M 525M EV / Sales 2019
-
EV / Sales 2020 -
Free-Float
-
Yield 2019 *
-
Yield 2020 -
Manager TitleAgeSince
Chief Executive Officer - 04/08/2025
Director of Finance/CFO 57 31/07/2025
Chief Tech/Sci/R&D Officer - 31/03/2023
Director TitleAgeSince
Chairman 67 20/10/2020
Director/Board Member - 19/10/2020
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap.
27/01/21Free

Chief Executive Officer

11,075,869 3.8998%
27/01/21Free

Chairman

1,384,483 0.4875%

Financials

2019 2020
Net sales - -
Net income -17.33M -14.99M -13.8M -12.93M -24.24M -1.65B -24.61M -164M -63.55M -802M -65.05M -63.66M -2.78B -11.14M -9.63M -8.87M -8.31M -15.58M -1.06B -15.81M -105M -40.83M -515M -41.79M -40.9M -1.78B
Net Debt 2.89M 2.5M 2.3M 2.15M 4.04M 275M 4.1M 27.24M 10.58M 134M 10.83M 10.6M 462M 2.84M 2.45M 2.26M 2.12M 3.97M 270M 4.03M 26.79M 10.41M 131M 10.65M 10.43M 455M
Logo GI Dynamics, Inc.
GI Dynamics, Inc. is a medical device company. The Company designs and applies device and disease management solutions for the treatment of metabolic disease. The Company designs, develops, manufactures and markets medical devices for non-surgical approaches to treat type II diabetes and obesity. The Company's product, EndoBarrier, is an endoscopically-delivered device therapy, which is approved for the treatment of obese type II diabetes with body mass index (BMI) greater than or equal to 30 kilogram/square meter (kg/m2), or obese patients with BMI greater than or equal to 30 kg/m2 with greater than or equal to one comorbidities, or obese patients with BMI over 35 kg/m2. EndoBarrier is an incision-free, non-anatomy altering solution designed to specifically mimic the duodenal-jejunal exclusion created by gastric bypass surgery.
Employees
-
Sector
-
  1. Stock Market
  2. Stocks
  3. GIDYL Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!